An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- PMID: 35191898
- PMCID: PMC12878646
- DOI: 10.1188/22.ONF.142-150
An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Abstract
Objectives: To prospectively assess cognitive function, anthropomorphic measures, and bone mineral density in men receiving androgen deprivation therapy (ADT) for prostate cancer; explore relationships between cognitive function and central adiposity; and gather preliminary data from a personalized education, exercise, and nutrition intervention.
Sample & setting: 33 participants consented from a randomized controlled intervention trial.
Methods & variables: Neurocognitive performance and self-report of cognitive function were assessed at baseline and 6 and 12 months. Dual-energy x-ray absorptiometry (DEXA) scans were obtained at baseline and 6 months.
Results: No between-group differences in cognitive function were demonstrated. Increased visceral adiposity was not associated with decrements in visuospatial abilities. Significant increases in fat mass without increases in body mass index or waist-hip ratio provided further evidence for DEXA as the preferred central adiposity measure.
Implications for nursing: Well-powered prospective research is needed to fully characterize the effects of ADT on cognitive function and the potential benefits of exercise and nutrition-based interventions.
Keywords: androgen deprivation; central adiposity; cognitive function; prostate cancer.
Figures
References
-
- Bi X, Seabolt L, Shibao C, Buchowski M, Kang H, Keil CD, . . . Silver, H.J. (2015). DXA-measured visceral adipose tissue predicts impaired glucose tolerance and metabolic syndrome in obese Caucasian and African-American women. European Journal of Clinical Nutrition, 69(3), 329–336. 10.1038/ejcn.2014.227 - DOI - PMC - PubMed
-
- Dahl A, Hassing LB, Fransson E, Berg S, Gatz M, Reynolds CA, & Pedersen NL (2010). Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 65A(1), 57–62. 10.1093/gerona/glp035 - DOI - PMC - PubMed
-
- Joly F, Aibhai SMH, Galica J, Park A, Yi Q-L, Wagner L, & Tannock IF (2006). Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. Journal of Urology, 176(6), 2443–2447. 10.1016/j.juro.2006.07.151 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical